Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The UiPath, Inc. (NYSE: PATH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, giving investors and researchers a structured view of how this software publisher reports on its automation and AI business. As a public company, UiPath files documents with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic filings.
Recent Form 8-K filings for UiPath include results of operations and financial condition, where the company furnishes press releases announcing quarterly financial results. These filings typically reference revenue performance, Annualized Renewal Run-rate (ARR), dollar-based net retention rate, and other operating metrics, along with management commentary on the progress of UiPath’s agentic automation strategy. Another 8-K filing details matters submitted to a vote of security holders at the annual meeting, such as director elections, advisory votes on executive compensation, and ratification of the independent registered public accounting firm.
UiPath also uses Form 8-K to disclose other material events, such as the adoption of a Rule 10b5-1 trading plan by an entity controlled by its founder and chief executive officer. That filing explains the plan’s purpose within a personal long-term investment strategy and notes that the shares subject to the plan represent a limited portion of the individual’s holdings, while the individual remains a significant controlling stockholder.
On Stock Titan, UiPath filings are updated as they appear on EDGAR, and AI-powered summaries help explain the substance of each document. Users can quickly understand the context of earnings-related 8-Ks, governance disclosures, and other material events without reading every line of the underlying filing. For more detailed analysis, investors can review the full text of each filing alongside these AI-generated overviews.
UiPath (PATH) insider transaction: CEO and Chairman Daniel Dines, also a Director and 10% Owner, reported a sale of 45,000 shares of Class A common stock at $15.62 on 10/17/2025. The filing notes the sale was executed under a qualified Rule 10b5-1 trading plan.
Following the transaction, he beneficially owned 29,873,585 shares directly. An additional 240,000 shares are reported as indirectly owned by his spouse.
PATH common stock: a Form 144 notice discloses a proposed sale of 1,000,000 shares, with an aggregate market value $15,930,000. The filing lists Morgan Stanley Smith Barney LLC – Executive Financial Services as broker and an approximate sale date of 10/17/2025 on the NYSE.
The securities were acquired on 04/21/2021 as Founders Shares from the issuer; amount acquired was 1,000,000 shares. Shares outstanding were 453,568,899. The filing also reports recent Rule 10b5-1 sales by ICE VULCAN HOLDING LIMITED, including 122,734 shares on 10/16/2025 for $2,112,411.69.
UiPath, Inc. (PATH) insider transaction: CEO, Chairman, Director, and 10% owner Daniel Dines reported a sale of 122,734 Class A shares on 10/16/2025. The sale was executed under a qualified Rule 10b5-1 trading plan. The filing notes a weighted average price of $17.2113, with individual trade prices ranging from $16.7400 to $17.4700.
Following the reported transactions, the filing lists 29,918,585 Class A shares as directly beneficially owned and 240,000 shares indirectly beneficially owned by spouse. The form also references indirect holdings through Ice Vulcan Holding Limited, over which Mr. Dines has sole voting and investment power via control of the parent entity.
UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/16/2025, the officer sold a total of 10,000 Class A shares in two trades executed under a pre‑arranged Rule 10b5-1 plan.
The first sale was 8,300 shares at a weighted average price of $16.2211 (price range $15.8100–$16.7700). The second was 1,700 shares at a weighted average price of $16.9918 (range $16.8100–$17.4900). Following these transactions, the officer beneficially owns 222,776 shares, held directly.
UiPath (PATH) filed a Form 144 notice for a proposed sale of 10,000 common shares with an aggregate market value of $166,900. The filing lists Morgan Stanley Smith Barney LLC as broker, an approximate sale date of 10/16/2025, and trading on the NYSE. The shares were acquired via restricted stock units from the issuer on 01/01/2024. Shares outstanding were 453,568,899.
The filing also reports recent Rule 10b5-1 sales for Hitesh Ramani: 10,000 shares on 10/13/2025 for $170,056, 10,000 on 10/14/2025 for $165,351, and 10,000 on 10/15/2025 for $166,801.
UiPath (PATH) reported an insider transaction by its GC & Chief Legal Officer, Brad Brubaker. On 10/15/2025, he sold 27,580 shares of Class A common stock in an open-market transaction executed under a Rule 10b5-1 trading plan.
The reported average price was $16.6761, with trades occurring in a range from $16.2100 to $17.2000. Following the sale, Brubaker beneficially owns 662,939 shares, held directly.
UiPath (PATH) CEO Daniel Dines reported an insider sale. A Form 4 shows the sale of 122,734 shares of Class A common stock on 10/15/2025, executed pursuant to a Rule 10b5-1 trading plan.
The filing lists a price of $16.9245 and notes trades occurred within a range of $16.7200 to $17.0600. Footnotes indicate certain shares are held through Ice Vulcan Holding Limited, with Mr. Dines retaining sole voting and investment power through affiliated entities. He is identified as Director, CEO and Chairman, and a 10% Owner.
UiPath (PATH) filed a Form 4 reporting that its Chief Accounting Officer sold Class A common stock pursuant to a Rule 10b5-1 plan. The officer sold 10,000 shares on 10/14/2025 at an average price of $16.5351 (price range $16.1200–$16.9000) and 10,000 shares on 10/15/2025 at an average price of $16.6801 (price range $16.2400–$17.1100).
Following these transactions, the reporting person beneficially owned 232,776 shares, held directly.
UiPath (PATH) filed a Form 144 notice for a proposed sale of restricted securities by an affiliate. The filing lists 10,000 common shares to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $164,800, on or about 10/15/2025 on the NYSE. Shares outstanding were 453,568,899.
The shares were acquired as Restricted Stock Units from the issuer on 01/01/2024. The notice also reports recent activity under a 10b5-1 framework: on 10/14/2025, 10,000 shares sold for $165,351, and on 10/13/2025, 10,000 shares sold for $170,056.
UiPath (PATH) insider BRAD C BRUBAKER filed a Form 144 notice to sell company stock. The filing lists 27,580 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $454,518.40. The approximate sale date is 10/15/2025, and the shares trade on the NYSE.
The shares to be sold were acquired on 07/01/2023 via restricted stock units. As context, shares outstanding were 453,568,899. The notice also lists recent plan-driven sales: 66,665 shares on 10/06/2025 for $999,985.58 and 16,083 shares on 09/30/2025 for $241,262.69, each under a Rule 10b5-1 trading plan.
Form 144 is a notice of proposed sales by an affiliate and does not itself execute the transaction.